Johnson & Johnson Earnings and Outlook - Bullish Signals Despite Broader Market Fears

# Johnson & Johnson Stock Analysis: Strong Q4 Earnings, Bullish Outlook & Price Target Insights In this episode, we dive into Johnson & Johnson's (JNJ) current market performance, trading at approximately $219.72 per share with technical indicators suggesting a bullish trend despite market fear. Discover how JNJ's impressive Q4 results—with revenue reaching $24.56 billion (up 9.1% year-over-year)—exceeded analyst expectations and what this means for investors. We explore the Trump administration deal reducing US drug prices while securing tariff exemptions and accelerating JNJ's $55 billion domestic manufacturing initiative. Plus, learn why analysts maintain a "moderate buy" consensus with price targets ranging from $212 to $250, supported by JNJ's strong MedTech division and attractive 2.33% dividend yield. Essential listening for healthcare investors navigating JNJ's outlook amid talc litigation concerns and upcoming FY2026 earnings projections. For more http://www.quietplease.ai Stock up on these deals https://amzn.to/3QFpYIX This content was created in partnership and with the help of Artificial Intelligence AI.